Towards the end of 2019 we saw a much needed breakthrough for thousands of men living with advanced prostate cancer. The drug, olaparib (pronounced o-la-par-ib), was shown to prevent prostate cancer from progressing in men with very advanced and aggressive forms of the disease, who are already resistant to other treatments.
Olaparib is a giant leap forward in treatment, not just because it’s the world’s first precision medicine for prostate cancer, but because it tackles the disease from a completely new angle.
Bet we're not done yet.
Professor Simon Mackay, from the University of Strathclyde, has been working towards a new treatment for prostate cancer for the last decade. His work could bring another breakthrough for men living with advanced disease. He is now on the home stretch, and adding the finishing touches to his drug to hopefully take it into clinical trials.
You can be part of making this breakthrough a reality for thousands of men.Donate now
We are particularly excited about this potential treatment because it could stop prostate cancer from growing and becoming advanced, and also help men respond to treatments for longer without becoming resistant.
New treatments like olaparib are an important and promising step in the right direction. But there are still thousands of men with advanced disease that need new options for treatment. Men like your fathers, sons, brothers and friends. Men like Lloyd Pinder.
Lloyd was just 44 when he was diagnosed with advanced prostate cancer. With a wife and two young children, the news was devastating.
It's research into new treatments that keep me hopeful. It could mean I'm able to function with prostate cancer and live to see my daughters grow up.
You can help us get one step closer to bringing pioneering new treatments to men who need them most, please donate today.